Nucleoside Antimetabolite/Analog

Items 1651-1700 of 1704

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Purine Nucleoside Analog

    2′-Deoxy-N-methylguanosine is a purine nucleoside analog primarily targeting DNA synthesis pathways. This compound exhibits significant antitumor activity, particularly in the context of indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic applications.
  2. Pyrimidinone

    1-Methylcytosine is a pyrimidinone that functions as a nucleobase in hachimoji DNA, pairing specifically with isoguanine. This compound exhibits weak antiproliferative activity against cervical cancer cells, making it a valuable tool for cancer research. Its unique properties facilitate studies in nucleic acid chemistry and the exploration of alternative genetic systems in oncological applications.
  3. Bicyclic Nucleosid

    2’-O,4’-C-Methyleneuridine is a bicyclic nucleoside that serves as a structural analog of natural ribonucleosides. It exhibits significant antiviral activity by inhibiting viral RNA polymerases, making it a valuable tool in virology research. This compound has applications in studying nucleotide metabolism and the development of antiviral therapies.
  4. Purine Nucleoside Analog

    6-Methylmercaptopurine riboside is a purine nucleoside analog that exhibits significant antitumor activity, primarily effective against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research into therapeutic strategies targeting various malignancies.
  5. Purine Nucleoside Analog

    2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone is a purine nucleoside analog known for its potential antitumor activity. This compound exhibits biological effects such as inhibition of DNA synthesis and induction of apoptosis, making it relevant for research into the treatment of indolent lymphoid malignancies. It can be synthesized from D-ribose through Fischer glycosylation with methanol, providing a useful tool in anticancer studies aimed at understanding and combating lymphoid malignancies.
  6. Purine Nucleoside Analog

    L-Threonolactone, a purine nucleoside analog, exhibits significant antitumor activity, particularly effective against indolent lymphoid malignancies. Its biological activity is attributed to mechanisms such as inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, allowing for the exploration of therapeutic strategies targeting nucleoside metabolism and cancer cell proliferation.
  7. Purine Nucleoside

    8-Hydroxyadenosine is a modified purine nucleoside that serves as a marker for oxidative stress in nucleic acids. It plays a crucial role in cellular processes and is involved in the regulation of various biological activities, including gene expression and DNA repair mechanisms. This compound is commonly utilized in research studies focused on oxidative damage, cellular response to stress, and the examination of RNA modifications.
  8. Active Compound

    Orotic acid zinc acts as an active compound involved in the biosynthesis of pyrimidine nucleotides and RNA. It is released as a product from mitochondrial dihydroorotate dehydrogenase (DHODH) and subsequently converted to UMP by UMP synthase in the cytoplasm. This compound is utilized as a biomarker in newborn screening for urea cycle disorders and has been shown to induce hepatic steatosis and hepatomegaly in rodent models, making it relevant for studies in metabolic and liver disorders.
  9. Purine Nucleoside Analog

    2'-Deoxy-N3-methylcytidine hydriodide is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily mediated through the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound serves as a valuable research tool for investigating therapeutic strategies in oncology.
  10. Purine Nucleoside Analog

    1-(a-D-ribofuranosyl)uracil is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for research in cancer biology and therapeutic development. This reagent is suited for studies focusing on nucleic acid metabolism and the molecular pathways involved in tumor growth and progression.
  11. Purine Nucleoside Analog

    Dideoxycytidinene, a purine nucleoside analog, primarily targets DNA synthesis processes. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in cancer therapeutics.
  12. Purine Nucleoside Analog

    2'-Deoxy-2'-fluoro-β-D-arabinocytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound holds promise for studies aimed at understanding and developing therapies for various hematological cancers.
  13. Purine Nucleoside Analog

    6-Chloroguanineriboside is a purine nucleoside analog that serves as a substrate for various nucleoside kinases. It demonstrates low affinity for guanosine binding sites, with a Ki value of 253.1 μM in rat brain tissues. This compound can be utilized in research related to nucleoside metabolism and the pharmacological effects of purine analogs in neurological studies.
  14. Isomer

    (2S,3R,5S)-7-Deaza-2'-deoxy-7-iodoadenosine is an isomeric variant of 7-Deaza-2'-deoxy-7-iodoadenosine, serving primarily as a control in biochemical experiments. This modified oligonucleotide includes 7-Deazaadenine and is utilized in research applications focused on nucleic acid interactions and modifications. Its unique structure allows for the exploration of various biological processes involving adenine analogs.
  15. Nucleoside Analog

    3'-NH2-ddA (3'-Amino-2',3'-dideoxyadenosine) is a nucleoside analog that serves as an important building block for the synthesis of nucleic acids. Its structural features facilitate incorporation into DNA and RNA, making it valuable for studies involving genetic manipulation and molecular biology applications. This reagent is essential for developing advanced nucleic acid-based technologies such as antisense oligonucleotides and gene editing strategies.
  16. Deoxyribonucleoside

    DMT-dI (5'-O-DMT-dI) is a modified deoxyribonucleoside featuring a hypoxanthine base. It serves as a precursor for synthesizing convertible nucleoside derivatives, which are valuable for generating modified oligonucleotides that can effectively target specific genes involved in gene editing applications. DMT-dI is particularly useful for researching conditions and disorders influenced by adenosine metabolism.
  17. Cytidine Analogue

    N-Benzoylcytidine is a cytidine analogue that acts as a substrate for uracil-cytidine kinases (UCK1 and UCK2). It is integral to the synthesis of 2-OH protective groups for solid-phase RNA synthesis and is utilized in the production of synthetic oligonucleotides. This compound has applications in UV induction and targeted gene silencing in zebrafish embryos, making it a valuable tool in molecular biology research.
  18. Purine Nucleoside Analog

    2’-Azido-2’-deoxycytidine is a purine nucleoside analogue that exhibits significant anticancer properties by inhibiting DNA synthesis and inducing apoptosis, particularly in indolent lymphoid malignancies. This compound serves as a versatile click chemistry reagent, containing an azide group that facilitates copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) with alkyne, DBCO, or BCN-containing molecules. Additionally, 2’-Azido-2’-deoxycytidine requires dual phosphorylation to function as an inhibitor of ribonucleotide reductase, positioning it as a valuable tool in cancer research and therapeutic development.
  19. Purine Nucleoside Analog

    6-Methylpurine riboside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research. This compound is utilized in investigations focused on therapeutic strategies targeting nucleoside metabolism and cell proliferation.
  20. Purine Nucleoside Analog

    3'-Azido-3'-deoxyadenosine is a purine nucleoside analog that exhibits potent antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects stem from mechanisms such as inhibition of DNA synthesis and induction of apoptosis. In addition to its biological applications, 3'-Azido-3'-deoxyadenosine functions as a click chemistry reagent, featuring an azide group that participates in copper-catalyzed azide-alkyne cycloaddition (CuAAC) and strain-promoted azide-alkyne cycloaddition (SPAAC) with alkyne-containing molecules. This versatility makes it a valuable tool in chemical biology and medicinal chemistry research.
  21. Purine Nucleoside Analog

    3′-Deoxy-3′-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activity. This compound primarily acts by inhibiting DNA synthesis and inducing apoptosis in neoplastic cells. Its application in research includes studying therapeutic strategies against indolent lymphoid malignancies, making it a valuable tool for cancer research and drug development.
  22. Nucleoside Analog

    (3R,5S)-5-O-DMT-3-pyrrolidinol is a nucleoside analog featuring a dimethoxytrityl (DMT) protecting group and a 3-pyrrolidinol framework. This compound plays a crucial role in the synthesis of nucleic acids, facilitating the development of oligonucleotides and other nucleic acid-based materials for research applications. Its unique structural properties make it a valuable reagent in chemical biology and molecular genetics studies.
  23. Adenosine Analog

    2’,3’,5’-Tri-O-acetyl adenosine is an adenosine analog that primarily targets adenosine receptors, serving as a potent smooth muscle vasodilator. This compound has been shown to exert inhibitory effects on cancer progression, making it a valuable tool in oncology research. It is useful for studying adenosine signaling pathways and their implications in various biological processes.
  24. Thymidine Analog

    5-Hydroxymethyl uridine is a thymidine analog that exhibits insertional activity towards replicated DNA. This compound is utilized in various research applications, including cell labeling and the monitoring of DNA synthesis. Its capacity to mimic natural thymidine makes it a valuable tool for studying DNA replication dynamics and cellular processes.
  25. Purine Nucleoside Analog

    5-Methyl-2′-O-methylcytidine is a purine nucleoside analog that exerts significant antitumor activity against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer biology and the development of therapeutic strategies targeting nucleoside metabolism.
  26. Purine Nucleoside Analog

    Spongosine, also known as 2-Methoxyadenosine, acts as a purine nucleoside analog. It exhibits significant antitumor activity, particularly in targeting indolent lymphoid malignancies. The compound's anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research applications.
  27. GTP Analogue

    5′-Guanylyl methylenediphosphonate sodium is a GTP analogue that acts as a specific, competitive inhibitor of GTP-dependent processes in protein synthesis. By mimicking GTP, it disrupts nucleotide binding, thereby affecting the translation mechanism in cells. This reagent is valuable for researchers investigating protein biosynthesis pathways and studying the regulatory roles of GTP in various cellular functions.
  28. ATP Analog

    3BrB-PP1 is an ATP-competitive analog designed to selectively inhibit protein kinases with mutations in the ATP-binding pocket, particularly targeting the Thr97 mutation within Sty1. This compound offers a unique tool for investigating the effects of ATP-binding site alterations on kinase activity. Its specificity makes it valuable for studying mutant forms of kinases in various biological contexts and cancer research.
  29. Nucleoside

    DMT-2'Fluoro-DG(IB) Amidite is a phosphoramidite nucleoside primarily targeting oligonucleotide synthesis. It facilitates the incorporation of 2'-fluoro modifications, allowing for the preparation of 4'-modified 2'-deoxy-2'-fluorouridine. This reagent is valuable in the study of nucleic acid structure and function, as well as in the development of therapeutic oligonucleotides.
  30. Adenosine Analog

    2,8-Dimethyladenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant vasodilatory effects on smooth muscle and has demonstrated potential in inhibiting cancer progression. It serves as a valuable tool for research in cardiovascular studies and cancer biology.
  31. Purine Nucleoside Analog

    2'-Deoxy-2'-fluoro-β-D-arabino-6-azauridine is a purine nucleoside analog that primarily targets DNA synthesis pathways. Exhibiting broad antitumor activity, it is particularly effective against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA replication and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic development in oncology.
  32. Cytidine Analog

    3′-O-Methylcytidine is a cytidine analog that functions as an inhibitor of DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it a valuable tool in cancer research. Its ability to modulate gene expression through epigenetic mechanisms positions it as an important reagent for studies focused on DNA methylation and its role in various biological processes.
  33. Pyrimidine Nucleoside

    L-Cytidine is a pyrimidine nucleoside that plays a crucial role as a building block of RNA. It is known to regulate the glial glutamate cycle and influence brain phospholipid metabolism, catecholamine synthesis, and mitochondrial function. This compound is valuable in research applications involving RNA biochemistry, neurobiology, and cellular metabolism.
  34. Adenosine Derivative

    Adenosine 5′-monophosphoramidate sodium is an adenosine derivative that serves as an intermediate in nucleotide synthesis. It significantly influences the accumulation of cyclic AMP, playing a critical role in various cellular signaling pathways. This reagent is valuable for research applications focused on the modulation of adenine nucleotide metabolism and cyclic nucleotide signaling.
  35. Purine Nucleoside Analog

    2’-O-(2-Methoxyethyl) inosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in cancer therapeutics and molecular biology. This reagent may facilitate investigations into the roles of purine metabolism and nucleoside signaling pathways in cancer progression.
  36. Purine Nucleoside Analog

    1-O-Acetyl-2-O-benzoyl-3-O-tert-butyldiphenylsilyl-L-threofuranose is a purine nucleoside analog that primarily targets DNA synthesis pathways. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of nucleic acid synthesis and the induction of apoptotic pathways, making it valuable for research in cancer therapeutics and drug development.
  37. Purine Nucleoside Analog

    5-Bromocytidine is a purine nucleoside analog that exhibits broad antitumor activity against indolent lymphoid malignancies. Its anticancer mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic exploration. This compound is suitable for studies aimed at understanding nucleoside metabolism and the role of DNA replication in tumorigenesis.
  38. Nucleoside Antimetabolite/Analog

    5'-DMT-3'-TBDMS-Bz-rA is a nucleoside analog designed for use as an antimetabolite. This compound features protective and modification groups that enhance its stability and reactivity. It is suitable for various molecular biology applications, including oligonucleotide synthesis and nucleic acid research, where it can be utilized to study nucleoside function and metabolism.
  39. Purine Nucleoside Analog

    3'-Deoxycytidine is a purine nucleoside analog that primarily influences DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA replication and promoting apoptosis. It is utilized in various research applications aimed at understanding cancer mechanisms and developing therapeutic strategies.
  40. Purine Nucleoside Analog

    Alpha-Adenosine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies focused on the therapeutic effects of nucleoside analogs in treating various malignancies.
  41. Adenosine Analog

    N-Acetyladenosine is an adenosine analog that primarily functions as a smooth muscle vasodilator. This compound has demonstrated the ability to inhibit cancer progression, making it relevant in cancer research. N-Acetyladenosine is utilized in studies focusing on vascular biology and may serve as a therapeutic candidate in the development of anti-cancer strategies.
  42. Nucleoside Analog

    VP-U-6 is a nucleoside analog primarily utilized in oligonucleotide synthesis. This compound serves as a critical building block for the development of diverse oligonucleotides, enhancing the specificity and stability of nucleic acid interactions. VP-U-6 is instrumental in various applications, including antisense oligonucleotide design, RNA interference studies, and molecular diagnostic techniques.
  43. Intermediate

    5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine is an adenosine derivative primarily used as an intermediate in oligonucleotide synthesis. This compound facilitates the incorporation of adenosine units into nucleic acid sequences, enhancing the efficiency of synthetic procedures. Its stable protective groups make it suitable for various modifications in chemical biology and nucleic acid research.
  44. Nucleosides

    N6-Threonylcarbamoyladenosine is a modified nucleoside targeting tRNA molecules. This compound plays a crucial role in the post-transcriptional modification of tRNA, influencing its stability and function. Research applications include investigating tRNA structure-function relationships and studying the effects of nucleoside modifications on protein synthesis and translation efficiency.
  45. Antiviral Agents

    Ribavirin 5'-monophosphate dilithium is an active metabolite of ribavirin that predominantly inhibits inosine monophosphate (IMP) dehydrogenase. As a broad-spectrum antiviral agent, it is utilized in research to investigate viral replication mechanisms and assess therapeutic strategies against various viral infections. This compound's ability to modulate nucleotide synthesis positions it as a valuable tool in virology studies.
  46. Nucleoside Analog

    2'-O-POM-rA(Bz) is a nucleoside analog that serves as a key monomer for nucleic acid synthesis. It is utilized in the preparation of modified oligonucleotides and plays a crucial role in research applications involving RNA chemistry and therapeutic development. This compound enhances the stability and functionality of nucleic acid constructs, making it valuable in various biochemical studies.
  47. Purine Nucleoside Analog

    2’-O-Methyl-4-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable in research applications aimed at exploring novel cancer therapies and understanding the molecular pathways involved in tumor progression.
  48. Usherin Synthesis Promotor

    Ultevursen (QR-421a) is a single-stranded RNA oligonucleotide that acts as a splice-switching agent, designed to promote the skipping of exon 13 in the USH2A gene, which encodes usherin. This mechanism aims to halt vision loss associated with retinitis pigmentosa caused by mutations within this exon. Ultevursen has potential applications in gene therapy and research focused on treatments for genetic retinal diseases.
  49. Purine Nucleoside Analog

    2',3',5'-Tri-O-acetyl-2-thiouridine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable reagent for researchers studying cancer therapeutics and the molecular pathways involved in nucleoside metabolism.
  50. Adenosine Analog

    2-Chloro-2′-β-C-methyladenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits vasodilatory effects on smooth muscle and demonstrates the potential to inhibit cancer progression. It serves as a valuable tool for research applications focused on vascular biology and cancer therapeutics.

Items 1651-1700 of 1704

Page
per page
Set Descending Direction